Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […]

Related Keywords

Hong Kong , United States , American , , Tower Research Capital , Amneal Pharmaceuticals Trading , Pricet Rowe Associates Inc , Y Intercept Hong Kong Ltd , Nasdaq , Barclays , News Ratings For Amneal Pharmaceuticals Daily , American Century Companies Inc , Analyst Recommendations For Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Institutional Trading Of Amneal Pharmaceuticals , Amneal Pharmaceuticals , Get Free Report , Century Companies , Gate Manager , Research Capital , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Amrx , Medical , Ratings , Consensus ,